Many DNA tumor viruses cause tumors by inactivating host tumor suppressors that guard against cellular genomic alterations and/or regulate cell cycle. Stripped of these controls, infected cells cycle more often and accumulate mutations more or less passively. Very recently, however, it has become clear that active viral manipulation of programmed cell death (apoptosis) plays a key role in oncogenesis and in the course of virus infection. We propose to study the pathogenesis of malignant fibromatosis elicited by malignant rabbit fibroma virus (MV) as a function of the virus ability to manipulate apoptosis and cell cycle progression. MV causes disseminated fibromyxoid tumors, severe immune suppression and death. We have found that C7 early viral transcription factor is a major determinant of MV virulence. Infection with MV and transfection with C7 both: (i) upregulate p53, (ii) slow cell cycle and (iii) cause apoptosis. We propose here to define the mechanisms by which MV and C7 elicit apoptosis and the role of apoptosis in the pathogenesis of malignant fibromatosis. These studies will test the following hypotheses: Hypotheses: The ability of MV to elicit apoptosis determines to a large extent its ability to cause disseminated tumors, suppress immune function, and kill susceptible animals. Furthermore, C7 plays a major role in this apoptosis. To test these hypotheses, we will identify the cellular targets and effects on C7- induced apoptosis, and define the signaling pathways involved. Mutant MVs separately incorporating the apoptosis inhibitors Bcl-2 and P35 will be generated. Effects of P35 and Bcl-2 on virus replication, cellular proliferation, lymphocyte function, tumor development, and the course of MV infection will be studied both in vitro and in vivo. The mechanisms whereby C7 elicits apoptosis and modifies cell cycle progression will be determined. Thus, we hope to define the importance of apoptosis to the pathogenesis of malignant fibromatosis, and of C7 to apoptosis. These studies will help elucidate the mechanisms by which viruses may manipulate and subvert cellular survival and death mechanisms to replicate themselves, suppress immune function, and cause tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA044800-08
Application #
2655890
Study Section
Special Emphasis Panel (ZRG2-MEP (02))
Program Officer
Wong, May
Project Start
1988-03-01
Project End
2002-06-30
Budget Start
1998-09-01
Budget End
1999-06-30
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Pathology
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Duan, Yu-You; Wu, Jian; Zhu, Jian-Liang et al. (2004) Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors. Gastroenterology 127:1222-32
Strayer, D S; Lamothe, M; Wei, D et al. (2001) Generation of recombinant SV40 vectors for gene transfer. Methods Mol Biol 165:103-17
Strayer, D S (2000) Effective gene transfer using viral vectors based on SV40. Methods Mol Biol 133:61-74
Wali, A; Strayer, D S (1999) Comparative effects of virulent and avirulent poxviruses on cell cycle progression. Exp Mol Pathol 66:31-8
Zern, M A; Ozaki, I; Duan, L et al. (1999) A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line. Gene Ther 6:114-20
Wali, A; Strayer, D S (1999) Infection with vaccinia virus alters regulation of cell cycle progression. DNA Cell Biol 18:837-43
Kondo, R; Feitelson, M A; Strayer, D S (1998) Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent. Gene Ther 5:575-82
Milano Jr, J; Strayer, D S (1998) Effects of overexpression of Ran/TC4 mammalian cells in vitro. Exp Cell Res 239:31-9
Strayer, D S; Kondo, R; Milano, J et al. (1997) Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells. Gene Ther 4:219-25
Strayer, D S; Duan, L X; Ozaki, I et al. (1997) Titering replication-defective virus for use in gene transfer. Biotechniques 22:447-50

Showing the most recent 10 out of 23 publications